Clinical Trial Update: Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer [Phase 2]

View source ↗

Summary

Phase II study of gemcitabine plus carboplatin for metastatic or recurrent cholangiocarcinoma and gallbladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemzar (gemcitabine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Cholangiocarcinoma, Gallbladder Cancer | Phase 2 | Status: COMPLETED